Peter Rothausen joins the management team of Lundbeck Foundation
Peter Rothausen is appointed Senior Vice President, Financial Investments and Head of Invest.
Peter Rothausen takes on a new managing role as he joins the Leadership Team of Lundbeck Foundation.
Peter Rothausen is appointed Senior Vice President, Financial Investments and Head of Invest, as he joins the Leadership Team after Bertil From, former CFO, who has left the Lundbeck Foundation to start a new chapter in his career.
"Peter Rothausen has created excellent results with his team at Invest in the 41/2 years he has been responsible for the Foundation's financial investments. The investments have yielded solid returns and helped ensure that we have the financial robustness needed to support our subsidiaries and can continue to grant more than DKK 500 million annually to public research within health sciences. I am pleased to welcome Peter to the Leadership Team, where he will make a big difference for the Foundation in the future," says Lene Skole, CEO of the Lundbeck Foundation.
The promotion of Peter Rothausen is the last step in establishing the Foundation's new management team.
Peter Rothausen has been investment manager in the Lundbeck Foundation since the May 1, 2018. Peter has 20 years of experience in the financial sector – initially as a share analytic in Carnegie, FIH and Danske Bank, and within recent years as investment expert in, first, Danish and, thereafter, European shares. Prior to joining the Lundbeck Foundation he was Chief Portfolio Manager for Danske Capital’s share hedge fund. Peter holds an MSc in Finance & Accounting from Copenhagen Business School.
More about Lundbeckfonden | Invest.
The Lundbeck Foundation is an enterprise foundation encompassing a comprehensive range of enterprise and philanthropic activities – all united by its strong purpose; Bringing Discoveries to Lives. The Foundation is the long-term and engaged owner of several international healthcare companies – Lundbeck, Falck and ALK – and an active investor in business, science and people through its commercial investments in the financial markets; in biotech companies based on Danish research and through philanthropic grants to science talents and programmes in Danish universities. The Foundation’s philanthropic grants amount to more than DKK 500m annually primarily focusing on the brain – including the world’s largest personal prize for neuroscience, The Brain Prize.
